New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

by Impact Journals LLCFigure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and AplanA new research perspective titled "A m
Oncology January 07,2024
Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

by Impact Journals LLCFigure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and AplanA new research perspective titled "A m
Oncology January 07,2024
Team successfully generates mouse models for two subtypes of multiple myeloma

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl
Oncology January 07,2024
Team successfully generates mouse models for two subtypes of multiple myeloma

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl
Oncology January 07,2024
Team reports on development of potential new generic treatment for multiple types of cancer

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic
Oncology January 07,2024
Team reports on development of potential new generic treatment for multiple types of cancer

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic
Oncology January 07,2024
Image-guided adaptive radiation treatments reduce short-term side effects for patients with prostate cancer

Image-guided adaptive radiation treatments reduce short-term side effects for patients with prostate cancer

byWileyCredit: Pixabay/CC0 Public DomainA technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately ai
Oncology January 07,2024
Image-guided adaptive radiation treatments reduce short-term side effects for patients with prostate cancer

Image-guided adaptive radiation treatments reduce short-term side effects for patients with prostate cancer

byWileyCredit: Pixabay/CC0 Public DomainA technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately ai
Oncology January 07,2024
Breakthrough brings potential glioblastoma drug into focus

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T
Oncology January 07,2024
Breakthrough brings potential glioblastoma drug into focus

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T
Oncology January 07,2024
Treatment strategies for adenoid cystic carcinoma of the head and neck

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du
Oncology January 07,2024
Treatment strategies for adenoid cystic carcinoma of the head and neck

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du
Oncology January 07,2024
Uncontrolled heart risk factors common in head, neck squamous cell cancer

Uncontrolled heart risk factors common in head, neck squamous cell cancer

by Elana GotkineThe burden of suboptimally controlled cardiovascular (CV) risk factors and incident risk of stroke and myocardial infarction (MI) are considerable in patients with head and neck squamo
Oncology January 07,2024
Uncontrolled heart risk factors common in head, neck squamous cell cancer

Uncontrolled heart risk factors common in head, neck squamous cell cancer

by Elana GotkineThe burden of suboptimally controlled cardiovascular (CV) risk factors and incident risk of stroke and myocardial infarction (MI) are considerable in patients with head and neck squamo
Oncology January 07,2024
Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

by ECOG-ACRIN Cancer Research Group"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for
Oncology January 07,2024
Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting

by ECOG-ACRIN Cancer Research Group"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for
Oncology January 07,2024
Head and neck cancer: Identifying markers to facilitate better treatment in the future

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic
Oncology January 07,2024
Head and neck cancer: Identifying markers to facilitate better treatment in the future

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic
Oncology January 07,2024
Head and neck cancer organoids as a step towards personalized treatments

Head and neck cancer organoids as a step towards personalized treatments

byHubrecht InstituteHNC organoids from the biobank. Credit: Organoid group, copyright Hubrecht Institute.Head and neck cancer (HNC) is an overarching term used for several types of cancer, inclu
Oncology January 07,2024
Head and neck cancer organoids as a step towards personalized treatments

Head and neck cancer organoids as a step towards personalized treatments

byHubrecht InstituteHNC organoids from the biobank. Credit: Organoid group, copyright Hubrecht Institute.Head and neck cancer (HNC) is an overarching term used for several types of cancer, inclu
Oncology January 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com